NYSEAMERICAN:AMPE - Ampio Pharmaceuticals Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $4.00
  • Forecasted Upside: 119.78 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$1.82
▼ -0.06 (-3.19%)

This chart shows the closing price for AMPE by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Ampio Pharmaceuticals Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AMPE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AMPE

Analyst Price Target is $4.00
▲ +119.78% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Ampio Pharmaceuticals in the last 3 months. The average price target is $4.00, with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 119.78% upside from the last price of $1.82.

This chart shows the closing price for AMPE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 1 polled investment analysts is to buy stock in Ampio Pharmaceuticals.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/29/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/28/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/26/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/24/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/23/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/23/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/22/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/21/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
1/22/2021Roth CapitalReiterated RatingBuy$4.00
12/19/2019Roth CapitalInitiated CoverageBuy$4.00
12/18/2019Roth CapitalReiterated RatingBuy
6/30/2016Janney Montgomery ScottReiterated RatingPositive
(Data available from 6/21/2016 forward)
Ampio Pharmaceuticals logo
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunology-based therapies for the treatment of prevalent inflammatory conditions in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-016, an intravenous treatment that is in Phase I/II clinical trial for COVID-19 patients with respiratory illness; and AP-014, an inhaled treatment that is in Phase I clinical trial for COVID-19 induced respiratory distress. The company is headquartered in Englewood, Colorado.
Read More

Today's Range

Now: $1.82
Low: $1.81
High: $1.92

50 Day Range

MA: $1.48
Low: $0.84
High: $2.76

52 Week Range

Now: $1.82
Low: $0.53
High: $2.98

Volume

87,506 shs

Average Volume

2,749,292 shs

Market Capitalization

$356.15 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.82

Frequently Asked Questions

What sell-side analysts currently cover shares of Ampio Pharmaceuticals?

The following Wall Street research analysts have issued reports on Ampio Pharmaceuticals in the last year: Roth Capital, and Zacks Investment Research.
View the latest analyst ratings for AMPE.

What is the current price target for Ampio Pharmaceuticals?

1 Wall Street analysts have set twelve-month price targets for Ampio Pharmaceuticals in the last year. Their average twelve-month price target is $4.00, suggesting a possible upside of 119.8%. Roth Capital has the highest price target set, predicting AMPE will reach $4.00 in the next twelve months. Roth Capital has the lowest price target set, forecasting a price of $4.00 for Ampio Pharmaceuticals in the next year.
View the latest price targets for AMPE.

What is the current consensus analyst rating for Ampio Pharmaceuticals?

Ampio Pharmaceuticals currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe AMPE will outperform the market and that investors should add to their positions of Ampio Pharmaceuticals.
View the latest ratings for AMPE.

What other companies compete with Ampio Pharmaceuticals?

How do I contact Ampio Pharmaceuticals' investor relations team?

Ampio Pharmaceuticals' physical mailing address is 373 Inverness Pkwy Ste 200, ENGLEWOOD, CO 80112-5898, United States. The specialty pharmaceutical company's listed phone number is (720) 437-6500. The official website for Ampio Pharmaceuticals is ampiopharma.com.